Literature DB >> 21824935

Integrating information from novel risk factors with calculated risks: the critical impact of risk factor prevalence.

Albertus J Kooter1, Piet J Kostense, Jan Groenewold, Abel Thijs, Naveed Sattar, Yvo M Smulders.   

Abstract

Mesh:

Year:  2011        PMID: 21824935     DOI: 10.1161/CIRCULATIONAHA.111.035725

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  10 in total

1.  Using the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysis.

Authors:  Mark J Pletcher; Michael Pignone; Stephanie Earnshaw; Cheryl McDade; Kathryn A Phillips; Reto Auer; Lydia Zablotska; Philip Greenland
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-03-11

2.  2016 European Guidelines on cardiovascular disease prevention in clinical practice : The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts).

Authors:  Massimo F Piepoli
Journal:  Int J Behav Med       Date:  2017-06

3.  Risk Factors for 1-Year Graft Loss After Kidney Transplantation: Systematic Review and Meta-Analysis.

Authors:  Farid Foroutan; Erik Loewen Friesen; Kathryn Elizabeth Clark; Shahrzad Motaghi; Roman Zyla; Yung Lee; Rakhshan Kamran; Emir Ali; Mitch De Snoo; Ani Orchanian-Cheff; Christine Ribic; Darin J Treleaven; Gordon Guyatt; Maureen O Meade
Journal:  Clin J Am Soc Nephrol       Date:  2019-09-20       Impact factor: 8.237

Review 4.  Stroke risk calculators in the era of electronic health records linked to administrative databases.

Authors:  Adam Richards; Eric M Cheng
Journal:  Stroke       Date:  2012-11-29       Impact factor: 7.914

5.  2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors:  Massimo F Piepoli; Arno W Hoes; Stefan Agewall; Christian Albus; Carlos Brotons; Alberico L Catapano; Marie-Therese Cooney; Ugo Corrà; Bernard Cosyns; Christi Deaton; Ian Graham; Michael Stephen Hall; F D Richard Hobbs; Maja-Lisa Løchen; Herbert Löllgen; Pedro Marques-Vidal; Joep Perk; Eva Prescott; Josep Redon; Dimitrios J Richter; Naveed Sattar; Yvo Smulders; Monica Tiberi; H Bart van der Worp; Ineke van Dis; W M Monique Verschuren; Simone Binno
Journal:  Eur Heart J       Date:  2016-05-23       Impact factor: 29.983

6.  Interpreting Hemoglobin A1C in Combination With Conventional Risk Factors for Prediction of Cardiovascular Risk.

Authors:  Jamie A Jarmul; Michael Pignone; Mark J Pletcher
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-09

7.  Individual risk.

Authors:  Ralph H Stern
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-02-13       Impact factor: 3.738

8.  Interpretation of the coronary artery calcium score in combination with conventional cardiovascular risk factors: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Mark J Pletcher; Christopher T Sibley; Michael Pignone; Eric Vittinghoff; Philip Greenland
Journal:  Circulation       Date:  2013-07-24       Impact factor: 29.690

9.  Use of low density lipoprotein particle number levels as an aid in statin treatment decisions for intermediate risk patients: a cost-effectiveness analysis.

Authors:  Dov Shiffman; Andre R Arellano; Michael P Caulfield; Judy Z Louie; Lance A Bare; James J Devlin; Olle Melander
Journal:  BMC Cardiovasc Disord       Date:  2016-12-07       Impact factor: 2.298

10.  Measuring improvement in fracture risk prediction for a new risk factor: a simulation.

Authors:  Lisa M Lix; William D Leslie; Sumit R Majumdar
Journal:  BMC Res Notes       Date:  2018-01-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.